Royalty Pharma plc (RPRX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 16.69B |
| Enterprise Value | 25.02B |
| P/E Ratio | 28.02 |
| PEG Ratio | -69.22 |
| Price/Sales Ratio | 9.46 |
| Price/Book Ratio | 3.37 |
| Enterprise/Revenue | 12.89 |
| Enterprise/EBITDA | 18.52 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.34 |
| Operating Margin | 0.68 |
AD
Management Effectiveness
| Return On Assets | 0.04 |
| Return On Equity | 0.13 |
Income Statement
| Revenue | 2.38B |
| Revenue/Share | 5.65 |
| Gross Profit | 2.38B |
| EBITDA | 1.64B |
| Net Income | 770.95M |
| Diluted EPS | 1.8 |
Balance Sheet
| Total Cash | 608.29M |
| Total Cash/Share | 1.41 |
| Total Debt | 8.96B |
| Total Debt/Equity | 1.3 |
| Current Ratio | 2.66 |
| Book Value Per Share | 23.01 |
Price History
| 52-Week Change | 53.82 |
| 52-Week High | 56.5 |
| 52-Week Low | 34.08 |
| Moving Average 50 Days | 51.91 |
| Moving Average 200 Days | 43.26 |
Statistics
| Average Volume | 3.61M |
| Shares Outstanding | 430.12M |
| % Held by Institutions | 82.64 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.91 |
| Trailing Annual Dividend Yield | 1.69 |
| Payout Ratio | 0.47 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
